Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
From: Implantable Cardioverter-Defibrillator ShocksEpidemiology, Outcomes, and Therapeutic Approaches JAMA Intern Med. 2013;173(10):859-865. doi:10.1001/jamainternmed.2013.428 Figure Legend: Figure 1. Appropriate and inappropriate implantable cardioverter-defibrillator (ICD) shock rates from the Multicenter Automatic Defibrillator Implantation Trial (MADIT II), the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT), Defibrillators in NonIschemic Cardiomyopathy Treatment Evaluation (DEFINITE) trial, and the Antiarrhythmics versus Implantable Defibrillators (AVID) trial. Date of download: 5/2/2017 Copyright © 2013 American Medical Association. All rights reserved. From: Implantable Cardioverter-Defibrillator ShocksEpidemiology, Outcomes, and Therapeutic Approaches JAMA Intern Med. 2013;173(10):859-865. doi:10.1001/jamainternmed.2013.428 Figure Legend: Figure 2. Reasons for inappropriate arrhythmia detection among patients with implantation of a combined cardiac resynchronization therapy–implantable cardioverter-defibrillator (ICD) device in the Multicenter InSync ICD Randomized Clinical Evaluation study. Date of download: 5/2/2017 Copyright © 2013 American Medical Association. All rights reserved. From: Implantable Cardioverter-Defibrillator ShocksEpidemiology, Outcomes, and Therapeutic Approaches JAMA Intern Med. 2013;173(10):859-865. doi:10.1001/jamainternmed.2013.428 Figure Legend: Figure 3. Reasons for inappropriate implantable cardioverter-defibrillator (ICD) shock among patients with ischemic cardiomyopathy and reduced left ventricular ejection fraction who received a primary prevention ICD in the Multicenter Automatic Defibrillator Implantation Trial. Date of download: 5/2/2017 Copyright © 2013 American Medical Association. All rights reserved.